HRP20050786B1 - Lokalna primjena fluorokinolina u lijeäśenju bakterijskih oboljenja dišnih organa - Google Patents
Lokalna primjena fluorokinolina u lijeäśenju bakterijskih oboljenja dišnih organaInfo
- Publication number
- HRP20050786B1 HRP20050786B1 HRP20050786AA HRP20050786A HRP20050786B1 HR P20050786 B1 HRP20050786 B1 HR P20050786B1 HR P20050786A A HRP20050786A A HR P20050786AA HR P20050786 A HRP20050786 A HR P20050786A HR P20050786 B1 HRP20050786 B1 HR P20050786B1
- Authority
- HR
- Croatia
- Prior art keywords
- fluoroquinolones
- treatment
- bacterial diseases
- respiratory organs
- locally applying
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
Izum se odnosi na sastave derivata kinolonkarboksilne kiseline, namijenjene za inhalaciju, u svrhu lokalne kontrole oboljenja dišnih organa, posebno plućnih oboljenja.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10305318A DE10305318A1 (de) | 2003-02-10 | 2003-02-10 | Behandlung bakteriell verursachter Lungenkrankheiten |
DE10305319A DE10305319A1 (de) | 2003-02-10 | 2003-02-10 | Behandlung bakteriell verursachter Lungenkrankheiten |
PCT/EP2004/000710 WO2004069253A1 (de) | 2003-02-10 | 2004-01-28 | Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20050786A2 HRP20050786A2 (en) | 2006-10-31 |
HRP20050786B1 true HRP20050786B1 (hr) | 2015-01-02 |
Family
ID=32851853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20050786AA HRP20050786B1 (hr) | 2003-02-10 | 2005-09-08 | Lokalna primjena fluorokinolina u lijeäśenju bakterijskih oboljenja dišnih organa |
Country Status (28)
Country | Link |
---|---|
US (2) | US8034817B2 (hr) |
EP (1) | EP1594500B1 (hr) |
JP (2) | JP4828405B2 (hr) |
KR (1) | KR101173696B1 (hr) |
AR (1) | AR043117A1 (hr) |
AT (1) | ATE482706T1 (hr) |
AU (1) | AU2004210399B2 (hr) |
BR (1) | BRPI0407368A (hr) |
CA (1) | CA2515262C (hr) |
CY (1) | CY1110998T1 (hr) |
DE (1) | DE502004011696D1 (hr) |
DK (1) | DK1594500T3 (hr) |
EC (1) | ECSP055959A (hr) |
HK (1) | HK1089380A1 (hr) |
HR (1) | HRP20050786B1 (hr) |
IL (1) | IL170027A (hr) |
MA (1) | MA27632A1 (hr) |
MX (1) | MXPA05008407A (hr) |
MY (1) | MY144714A (hr) |
NO (1) | NO331524B1 (hr) |
NZ (1) | NZ541681A (hr) |
PE (1) | PE20050189A1 (hr) |
PT (1) | PT1594500E (hr) |
RU (1) | RU2373937C9 (hr) |
SI (1) | SI1594500T1 (hr) |
TW (1) | TWI347843B (hr) |
UY (1) | UY28179A1 (hr) |
WO (1) | WO2004069253A1 (hr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ541681A (en) * | 2003-02-10 | 2009-02-28 | Bayer Healthcare Ag | Treatment of bacterial diseases of the respiratory organs by locally applying ciprofloxacin and its salts |
US7157455B2 (en) * | 2003-02-10 | 2007-01-02 | Hoffmann-La Roche Inc. | 4-Aminopyrimidine-5-one derivatives |
WO2006033713A2 (en) * | 2004-08-09 | 2006-03-30 | Chiron Corporation | Methods for ciprofloxacin inhalation |
CA2585859C (en) | 2004-10-29 | 2012-03-06 | President And Fellows Of Harvard College | Particles for treatment of pulmonary infection |
LT1901749T (lt) * | 2005-05-18 | 2016-10-25 | Raptor Pharmaceuticals Inc. | Aerozoliniai fluorchinolinai ir jų naudojimas |
US8524734B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
EP2285345A1 (en) | 2008-05-15 | 2011-02-23 | Novartis AG | Pulmonary delivery of a fluoroquinolone |
JP2012505222A (ja) | 2008-10-07 | 2012-03-01 | エムペックス・ファーマシューティカルズ・インコーポレーテッド | 肺炎症を低減するためのレボフロキサシンの吸入 |
JP2012505223A (ja) | 2008-10-07 | 2012-03-01 | エムペックス・ファーマシューティカルズ・インコーポレーテッド | 薬物動態の改善のためのエアゾールフルオロキノロン配合物 |
WO2010048341A1 (en) | 2008-10-22 | 2010-04-29 | Inspire Pharmaceuticals, Inc. | Method for treating cystic fibrosis |
AU2010289326B2 (en) | 2009-09-04 | 2015-09-24 | Horizon Therapeutics U.S. Holding Llc | Use of aerosolized levofloxacin for treating cystic fibrosis |
US9393243B1 (en) | 2015-07-14 | 2016-07-19 | Nilesh Parikh | Topical Ciprofloxacin compositions |
WO2018074880A2 (ko) * | 2016-10-20 | 2018-04-26 | 한국화학연구원 | 퀴놀린 4-온 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 폐렴의 예방 또는 치료용 약학적 조성물 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0209000A2 (de) * | 1985-07-16 | 1987-01-21 | Bayer Ag | Embonate von Chinoloncarbonsäuren und ihren Derivaten |
EP0504112A2 (de) * | 1991-03-14 | 1992-09-16 | Ciba-Geigy Ag | Pharmazeutische Aerosolformulierungen |
WO2001032144A1 (en) * | 1999-10-29 | 2001-05-10 | Inhale Therapeutic Systems, Inc. | Dry powder compositions having improved dispersivity |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3033157A1 (de) | 1980-09-03 | 1982-04-01 | Bayer Ag, 5090 Leverkusen | 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
US4670444B1 (en) * | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
DE3906365A1 (de) | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
FR2655545B1 (fr) * | 1989-12-11 | 1994-06-10 | Rhone Poulenc Sante | Nouvelle application therapeutique des derives des fluoroquinolones. |
DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
DE19633480A1 (de) * | 1996-08-20 | 1998-02-26 | Bayer Ag | Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren |
DE19812160C1 (de) * | 1998-03-20 | 1999-07-08 | Bayer Ag | Formkörper aus wirkstoffhaltigen thermoplastischen Polyurethanen |
AU5528299A (en) * | 1998-09-15 | 2000-04-03 | Naeja Pharmaceutical Inc. | Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s) |
DE19962470A1 (de) | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Verwendung von Chemotherapeutika |
DE10031043A1 (de) * | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
EP1490027A4 (en) * | 2002-03-05 | 2010-11-10 | Transave Inc | METHODS OF TRAPPING BIOACTIVE AGENT IN A LIPOSOME OR LIPID COMPLEX |
WO2003090715A2 (en) * | 2002-04-25 | 2003-11-06 | Nektar Therapeutics Uk Ltd | Particulate materials |
NZ541681A (en) * | 2003-02-10 | 2009-02-28 | Bayer Healthcare Ag | Treatment of bacterial diseases of the respiratory organs by locally applying ciprofloxacin and its salts |
-
2004
- 2004-01-28 NZ NZ541681A patent/NZ541681A/en unknown
- 2004-01-28 KR KR1020057014646A patent/KR101173696B1/ko active IP Right Grant
- 2004-01-28 MX MXPA05008407A patent/MXPA05008407A/es active IP Right Grant
- 2004-01-28 BR BRPI0407368-1A patent/BRPI0407368A/pt not_active Application Discontinuation
- 2004-01-28 RU RU2005128132/14A patent/RU2373937C9/ru not_active IP Right Cessation
- 2004-01-28 CA CA2515262A patent/CA2515262C/en not_active Expired - Fee Related
- 2004-01-28 DE DE502004011696T patent/DE502004011696D1/de not_active Expired - Lifetime
- 2004-01-28 WO PCT/EP2004/000710 patent/WO2004069253A1/de active Application Filing
- 2004-01-28 AT AT04705765T patent/ATE482706T1/de active
- 2004-01-28 SI SI200431572T patent/SI1594500T1/sl unknown
- 2004-01-28 EP EP04705765A patent/EP1594500B1/de not_active Expired - Lifetime
- 2004-01-28 DK DK04705765.8T patent/DK1594500T3/da active
- 2004-01-28 PT PT04705765T patent/PT1594500E/pt unknown
- 2004-01-28 AU AU2004210399A patent/AU2004210399B2/en not_active Ceased
- 2004-01-28 JP JP2006501628A patent/JP4828405B2/ja not_active Expired - Fee Related
- 2004-02-06 AR ARP040100382A patent/AR043117A1/es unknown
- 2004-02-06 UY UY28179A patent/UY28179A1/es not_active Application Discontinuation
- 2004-02-06 MY MYPI20040367A patent/MY144714A/en unknown
- 2004-02-09 TW TW093102878A patent/TWI347843B/zh not_active IP Right Cessation
- 2004-02-09 PE PE2004000145A patent/PE20050189A1/es not_active Application Discontinuation
- 2004-02-10 US US10/775,888 patent/US8034817B2/en not_active Expired - Fee Related
-
2005
- 2005-08-02 IL IL170027A patent/IL170027A/en active IP Right Grant
- 2005-08-10 EC EC2005005959A patent/ECSP055959A/es unknown
- 2005-09-08 HR HRP20050786AA patent/HRP20050786B1/hr not_active IP Right Cessation
- 2005-09-08 NO NO20054180A patent/NO331524B1/no not_active IP Right Cessation
- 2005-09-09 MA MA28491A patent/MA27632A1/fr unknown
-
2006
- 2006-09-07 HK HK06109963.8A patent/HK1089380A1/xx not_active IP Right Cessation
-
2010
- 2010-12-17 CY CY20101101161T patent/CY1110998T1/el unknown
-
2011
- 2011-06-08 JP JP2011128600A patent/JP2011173929A/ja active Pending
- 2011-07-28 US US13/192,893 patent/US20120010215A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0209000A2 (de) * | 1985-07-16 | 1987-01-21 | Bayer Ag | Embonate von Chinoloncarbonsäuren und ihren Derivaten |
EP0504112A2 (de) * | 1991-03-14 | 1992-09-16 | Ciba-Geigy Ag | Pharmazeutische Aerosolformulierungen |
WO2001032144A1 (en) * | 1999-10-29 | 2001-05-10 | Inhale Therapeutic Systems, Inc. | Dry powder compositions having improved dispersivity |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20050786B1 (hr) | Lokalna primjena fluorokinolina u lijeäśenju bakterijskih oboljenja dišnih organa | |
CY1118137T1 (el) | Αερολυμενες φθοροκινολονες και χρησεις αυτων | |
GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
ATE381535T1 (de) | Phenethanolaminderivate | |
MX2012004525A (es) | Compuestos. | |
NO20071577L (no) | Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer | |
MY150285A (en) | 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use | |
SE0301010D0 (sv) | Novel compounds | |
UA95199C2 (en) | Aqueous formulation of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | |
MY153258A (en) | Pyrazinone derivatives and their use inthe threatment of lung diseases | |
SE0301009D0 (sv) | Novel compounds | |
MX2008016134A (es) | Derivados de fenol para el tratamiento de enfermedades respiratorias. | |
PL1809288T3 (pl) | Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych | |
TW200604196A (en) | New quinuclidine derivatives and pharmaceutical compositions comprising them | |
UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
ME00830B (me) | Upotreba hitozana za povećanje brzine rasta nokta | |
MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
ATE455789T1 (de) | Substituierte nonadepsipeptide | |
ATE410443T1 (de) | Heterocyclyl-substituierte nonadepsipeptide | |
HK1106246A1 (en) | S-tenatoprazole monohydrated sodium salt and the use thereof in therapy s- | |
ME00489B (me) | NOVA SINERGIČKA KOMBINACIJA KOJA UKLJUČUJE ROFLUMILAST l FERMOTEROL | |
DE602005023184D1 (de) | Verhinderung von allergie bei kindern | |
ATE553088T1 (de) | Substituierte chinolone ii | |
ATE435868T1 (de) | Homogemcitabine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
PPPP | Transfer of rights |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE |
|
PNAN | Change of the applicant name, address/residence |
Owner name: BAYER PHARMA AG, DE |
|
PPPP | Transfer of rights |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE |
|
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20180112 Year of fee payment: 15 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20190128 |